Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,451,310 | 916,000 | 545,200 | 403,210 | 388,650 |
| Receivables | 3,540,930 | 3,191,000 | 2,756,450 | 2,733,000 | 2,835,520 |
| Inventories | 2,677,350 | 2,687,000 | 2,312,940 | 2,011,640 | 2,118,000 |
| Other current assets | 204,400 | 173,000 | 195,030 | 128,510 | 131,750 |
| TOTAL | $8,873,990 | $6,967,000 | $5,809,620 | $5,276,360 | $5,473,920 |
| Non-Current Assets | |||||
| PPE Net | 4,784,860 | 4,997,000 | 4,615,400 | 4,048,100 | 4,205,170 |
| Investments And Advances | 430,430 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,701,710 | 3,094,000 | 2,983,950 | 2,129,490 | 1,657,390 |
| TOTAL | $7,917,000 | $8,091,000 | $7,599,350 | $6,177,590 | $5,862,560 |
| Total Assets | $16,791,010 | $15,058,000 | $13,408,990 | $11,453,980 | $11,336,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 408,770 | 50,000 | 769,580 | 0 | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 5,310 | 14,010 |
| Other current liabilities | 4,139,210 | 3,586,000 | 3,091,960 | 2,860,610 | 2,831,790 |
| TOTAL | $4,897,200 | $4,192,000 | $4,888,000 | $5,135,450 | $5,236,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,237,730 | 3,372,000 | 2,163,010 | 1,720,090 | 1,996,540 |
| Other Non-Current Liabilities | 4,546,620 | 4,342,000 | 4,158,260 | 2,275,720 | 1,818,100 |
| TOTAL | $7,784,350 | $7,714,000 | $6,321,270 | $3,995,810 | $3,814,640 |
| Total Liabilities | $12,681,570 | $11,906,000 | $11,209,280 | $9,131,280 | $9,051,260 |
| Shareholders' Equity | |||||
| Common Shares | 774,240 | 721,000 | 599,730 | 506,900 | 606,340 |
| Retained earnings | 0 | 2,407,000 | 1,735,230 | 786,930 | 556,820 |
| Other shareholders' equity | 894,710 | -2,247,000 | -2,025,660 | -565,390 | -555,890 |
| TOTAL | $4,109,430 | $3,152,000 | $2,199,700 | $2,322,690 | $2,285,230 |
| Total Liabilities And Equity | $16,791,000 | $15,058,000 | $13,408,980 | $11,453,970 | $11,336,490 |